- CLINIMARK: GOOD BIOMARKER PRACTICE TO INCREASE THE NUMBER OF CLINICALLY VALIDATED BIOMARKERS.
- THE AIM OF THE CLINIMARK NETWORK IS TO ESTABLISH A ‘BEST BIOMARKER PRACTICE’ COMMUNITY TO SIGNIFICANTLY INCREASE THE NUMBER OF BIOMARKERS WITH REPRODUCIBLY DEMONSTRATED FEASIBILITY.
- IMPROVING THE PIPELINE FROM BIOMARKER RESEARCH TO MARKET.
- THE CLINIMARK NETWORK WILL FOCUS ON THE ANALYTICAL AND CLINICAL VALIDATION OF BIOMARKERS TO IMPROVE THE TRANSITION OF BIOMARKERS FROM THE RESEARCH TO THE MARKET PHASE.
Radbound Summer School
Integrative X-omics Analyses Empowering Personalised HealthcareDate:5 - 9 July 2021
CliniMark Cost Action Meeting September 21st - 22nd 2019, Athens - Greece
The CliniMARK Athens meeting presented unique opportunities for international collaborationson the disseminationof biomarker practice. During the meeting,participants agreed on a specific plan for writing several publications. Amongst them wasa review on analytical techniques forprotein biomarker validation focusing on multiplex detection of soluble biomarkers with clinicalapplications, which should be submitted by the end of 2019.
Handbook of Biomarkers and Precision Medicine.
"Handbook of Biomarkers and Precision Medicine" provides comprehensive insights into biomarker discovery and development which has driven the new era of Precision Medicine. A wide variety of renowned experts from government, academia, teaching hospitals, biotechnology and pharmaceutical companies share best practices, examples and exciting new developments.
Edited by Carini C, Fidock MD and van Gool AJ
Edited by Carini C, Fidock MD and van Gool AJ
COST CliniMARK Training School September 23rd - 27th 2019, Athens - Greece
A very successful Cost Clinimark training school was taking place from September 23 to 27, 2019 in Spetses Greece. More than 50 doctoral and post-doctoral students and academic trainers and experts discussed the "Approaches to discovery and validation of biomarkers".
Other consortia on biomarker: X-omics.nl and BIC
The Netherlands X-omics Initiative is a new facility as part of the National Roadmap for Large-Scale Research Infrastructures. It is partly funded by NWO with a total budget of 40 million euro. The project started on September 2018 and will last for ten years.
Biomarker Commercialization BIC. A consortium to assist biomarkers reach their full potential.
Biomarker Commercialization BIC. A consortium to assist biomarkers reach their full potential.
CliniMARK Kick-off meeting
The CliniMARK network has the goal of establishing "Best Biomarker Practice" (BBP) guidelines to radically improve the process from biomarker discovery to clinical use. The kick-off meeting was held at the COST offices in Brussels on March 14, 2017. A plan was developed to define BBP guidelines and to apply these guidelines for the validation of biomarkers with COPD as an example. The next meeting will be held from October 5 to 7, 2017, at the Erasmus MC (Rotterdam) in conjunction with the Biomarker Symposium. For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it..
